REVA Medical
IPORestore patient health for life
Public · $87.0M raised
- Website
- revamedical.com
- Total Funding
- $87.0M
- Last Round
- $45.0M Series BAug 2022
- Rounds
- 2
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
REVA Medical develops bioresorbable polymers for vascular applications and uses those biomaterials in implantable medical devices. Its Tyrocore polymer is used in Fantom Encore, a drug-eluting bioresorbable scaffold designed to treat coronary artery disease by restoring blood flow through blocked coronary arteries. Unlike permanent metallic stents, these scaffolds are designed to resorb in the body over time, with the goal of improving long-term outcomes and preserving future treatment options.
Summary
REVA Medical is a Biotech company. It has raised $87.0M in total across 2 rounds, most recently a $45.0M Series B round in Aug 2022. Investors include BioStar Capital.
Funding & Exit History
Aug 2022
Sign up to see all 3 events
Funding: Venture Round through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/reva-medical"><img src="https://indexed.vc/api/badge/company/reva-medical" alt="REVA Medical on Indexed.vc" width="260" height="76" /></a>